Tracer library / [18F]ApaScan

[18F]ApaScan

Also written as [18F]ApaScan
Radionuclide
F-18 t½ 109.77 min
Modality
PET
Production route
—
Stage
Preclinical
Syntheses indexed
1

What it is

Compound class
6-chloro-5-fluoro-1-(2-[18F]fluoroethyl)-2-(pyridin-3-yl)-1H-benzo[d]imidazole, a fluorine-18 labeled benzimidazole PET tracer
Target / mechanism
CYP11B2 (aldosterone synthase) PMID 41830677
Clinical application
Aldosterone-producing adenomas in patients with primary aldosteronism PMID 41830677
Theranostic pair
—

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
FASTlab
GE HealthCare
—HPLC29.2 ± 0.5%
not corrected
>99%—41830677
2026 Nucl Med Biol
The automated radiosynthesis process was optimized on a cassette-based FASTlab module integrated with preparative HPLC to afford the final formulation (ca. 5% ethanol). - The automated radiosynthesis achieved a non-decay-corrected yield of 29.2 ± 0.5%

Need this precursor?We can point you to suppliers for [18F]ApaScan, or handle the enquiry for you.

Get in touch

Quality control Preliminary - inferred from compound class

Ph. Eur. monograph
not verified No Ph. Eur. check is recorded for this entry.
USP monograph
not verified No USP check is recorded for this entry.
AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrity
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary); conventional nucleophilic 18F-fluorination assumed from isotope/compound class, no synthesis data confirming K222 use -> Kryptofix test (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [18F]ApaScan.

Get in touch

Notes

Added from reverse module search (stage 6); 1 article(s) with F-18. | Stage 28: added indication(s) end-adrenal from consolidated missing-rubric review. | Stage 30 (2026-09-18): Stage was 'preclinical (preparing for first-in-human studies)'; normalised to 'Preclinical', original wording kept here.
Ask a question